Forbes: Critical Reports Mount On Hepatitis C Pill Costs
The staggering costs of hepatitis C pills are the subject of two new medical journal reports pointing out that employers, insurers and the U.S. government will have difficulty paying for these pricey pills for years to come. The new issue of
0